抗组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体
Anti-Tissue Inhibitors Of Metalloproteinase 4 (TIMP4) Polyclonal Antibody
TIMP Metallopeptidase Inhibitor 4; Tissue Inhibitor of Metalloproteinases 4
- 编号FAA130Ra01
- 物种Rattus norvegicus (Rat，大鼠)相同的名称，不同的物种。
- 效价-
- Ig类型IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 激发波长
- 单次使用量
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 且适物种Mus musculus (Mouse，小鼠)
- 应用FCM
- 下载英文说明书 中文说明书
- 规格25test50test100test200test500test
- 价格¥ 720¥ 1200¥ 1920¥ 2400¥ 4200
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Mouse Hepa1-6 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-rat TIMP4 Polyclonal Antibody (Catalog FAA130Ra01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
通过ISO 9001、ISO 13485质量体系认证
用法
Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。
赠品
增值服务
相关产品
| 编号 | 适用物种：Rattus norvegicus (Rat，大鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| APA130Ra01 | 组织金属蛋白酶抑制因子4(TIMP4)活性蛋白 | Cell culture; Activity Assays. |
| RPA130Ra01 | 组织金属蛋白酶抑制因子4(TIMP4)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA130Ra01 | 组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体 | WB; IHC |
| FAA130Ra01 | 抗组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体 | FCM |
| LAA130Ra71 | 组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAA130Ra21 | 组织金属蛋白酶抑制因子4(TIMP4)单克隆抗体 | WB; IHC; ICC; IP. |
| SEA130Ra | 组织金属蛋白酶抑制因子4(TIMP4)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA130Ra | 组织金属蛋白酶抑制因子4(TIMP4)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA130Ra | 组织金属蛋白酶抑制因子4(TIMP4)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches[Plosone: Source] |